v3.25.2
Organization and Description of Business Operations - Proposed Business Combination (Details) - LIMINATUS PHARMA, LLC - Iris Acquisition Corp. ("Iris") (SPAC Company) - USD ($)
$ in Millions
 1 Months Ended
Oct. 23, 2024
Nov. 30, 2022
Forecast    
Business Combination [Line Items]    
Number of shares issued as business consideration, in exchange of acquiree's member units (in shares)   25,000,000
Aggregate equity value of acquirer $ 175 $ 250
Scenario where Iris Business Combination completed in accordance with the current terms of the agreement    
Business Combination [Line Items]    
Minimum gross proceeds from equity subscriptions $ 15